Molecular mechanisms and potential clinical applications of Campylobacter jejuni cytolethal distending toxin

Cheng Kuo Lai, Yu An Chen, Chun Jung Lin, Hwai Jeng Lin, Min Chuan Kao, Mei Zi Huang, Yu Hsin Lin, Chuan Chiang-Ni, Chih Jung Chen, U. Ging Lo, Li Chiung Lin, Ho Lin, Jer Tsong Hsieh, Chih Ho Lai

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Cytolethal distending toxin (CDT), a genotoxin produced by Campylobacter jejuni, is composed of three subunits: CdtA, CdtB, and CdtC. CdtB is a DNase that causes DNA double-strand breaks (DSB) in the nucleus resulting in cell cycle arrest at the G2/M stage and apoptosis. CdtA and CdtC bind to cholesterol-rich microdomains on the cytoplasmic membrane, a process required for the delivery of CdtB to cells. Although a unique motif associated with cholesterol-binding activity has been identified in other pathogens, the mechanism underlying the interaction between the CdtA and CdtC subunits and membrane cholesterol remains unclear. Also, the processes of cell uptake and delivery of CdtB in host cells and the translocation of CdtB into the nucleus are only partially understood. In this review, we focus on the underlying relationship among CDT, membrane cholesterol, and the intracellular trafficking pathway as a unique mechanism for C. jejuni-induced pathogenesis. Moreover, we discuss the clinical aspects of a possible therapeutic application of CDT in cancer therapy. Understanding the molecular mechanism of CDT-host interactions may provide insights into novel strategies to control C. jejuni infection and the development of potential clinical applications of CDT.

Original languageEnglish (US)
Article number9
JournalFrontiers in cellular and infection microbiology
Volume6
Issue numberFEB
DOIs
StatePublished - 2016

Fingerprint

Campylobacter jejuni
Cholesterol
G2 Phase Cell Cycle Checkpoints
Campylobacter Infections
Intracellular Membranes
Double-Stranded DNA Breaks
Deoxyribonucleases
Mutagens
Cell Membrane
cytolethal distending toxin
Apoptosis
Membranes
Therapeutics
Neoplasms

Keywords

  • Campylobacter jejuni
  • Cholesterol
  • Cytolethal distending toxin
  • Enzymatic activity
  • Trafficking

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Medicine(all)
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Molecular mechanisms and potential clinical applications of Campylobacter jejuni cytolethal distending toxin. / Lai, Cheng Kuo; Chen, Yu An; Lin, Chun Jung; Lin, Hwai Jeng; Kao, Min Chuan; Huang, Mei Zi; Lin, Yu Hsin; Chiang-Ni, Chuan; Chen, Chih Jung; Lo, U. Ging; Lin, Li Chiung; Lin, Ho; Hsieh, Jer Tsong; Lai, Chih Ho.

In: Frontiers in cellular and infection microbiology, Vol. 6, No. FEB, 9, 2016.

Research output: Contribution to journalReview article

Lai, CK, Chen, YA, Lin, CJ, Lin, HJ, Kao, MC, Huang, MZ, Lin, YH, Chiang-Ni, C, Chen, CJ, Lo, UG, Lin, LC, Lin, H, Hsieh, JT & Lai, CH 2016, 'Molecular mechanisms and potential clinical applications of Campylobacter jejuni cytolethal distending toxin', Frontiers in cellular and infection microbiology, vol. 6, no. FEB, 9. https://doi.org/10.3389/fcimb.2016.00009
Lai, Cheng Kuo ; Chen, Yu An ; Lin, Chun Jung ; Lin, Hwai Jeng ; Kao, Min Chuan ; Huang, Mei Zi ; Lin, Yu Hsin ; Chiang-Ni, Chuan ; Chen, Chih Jung ; Lo, U. Ging ; Lin, Li Chiung ; Lin, Ho ; Hsieh, Jer Tsong ; Lai, Chih Ho. / Molecular mechanisms and potential clinical applications of Campylobacter jejuni cytolethal distending toxin. In: Frontiers in cellular and infection microbiology. 2016 ; Vol. 6, No. FEB.
@article{bd5fa3978c4048c8bd8014642c7a25c0,
title = "Molecular mechanisms and potential clinical applications of Campylobacter jejuni cytolethal distending toxin",
abstract = "Cytolethal distending toxin (CDT), a genotoxin produced by Campylobacter jejuni, is composed of three subunits: CdtA, CdtB, and CdtC. CdtB is a DNase that causes DNA double-strand breaks (DSB) in the nucleus resulting in cell cycle arrest at the G2/M stage and apoptosis. CdtA and CdtC bind to cholesterol-rich microdomains on the cytoplasmic membrane, a process required for the delivery of CdtB to cells. Although a unique motif associated with cholesterol-binding activity has been identified in other pathogens, the mechanism underlying the interaction between the CdtA and CdtC subunits and membrane cholesterol remains unclear. Also, the processes of cell uptake and delivery of CdtB in host cells and the translocation of CdtB into the nucleus are only partially understood. In this review, we focus on the underlying relationship among CDT, membrane cholesterol, and the intracellular trafficking pathway as a unique mechanism for C. jejuni-induced pathogenesis. Moreover, we discuss the clinical aspects of a possible therapeutic application of CDT in cancer therapy. Understanding the molecular mechanism of CDT-host interactions may provide insights into novel strategies to control C. jejuni infection and the development of potential clinical applications of CDT.",
keywords = "Campylobacter jejuni, Cholesterol, Cytolethal distending toxin, Enzymatic activity, Trafficking",
author = "Lai, {Cheng Kuo} and Chen, {Yu An} and Lin, {Chun Jung} and Lin, {Hwai Jeng} and Kao, {Min Chuan} and Huang, {Mei Zi} and Lin, {Yu Hsin} and Chuan Chiang-Ni and Chen, {Chih Jung} and Lo, {U. Ging} and Lin, {Li Chiung} and Ho Lin and Hsieh, {Jer Tsong} and Lai, {Chih Ho}",
year = "2016",
doi = "10.3389/fcimb.2016.00009",
language = "English (US)",
volume = "6",
journal = "Frontiers in cellular and infection microbiology",
issn = "2235-2988",
publisher = "Frontiers Media S. A.",
number = "FEB",

}

TY - JOUR

T1 - Molecular mechanisms and potential clinical applications of Campylobacter jejuni cytolethal distending toxin

AU - Lai, Cheng Kuo

AU - Chen, Yu An

AU - Lin, Chun Jung

AU - Lin, Hwai Jeng

AU - Kao, Min Chuan

AU - Huang, Mei Zi

AU - Lin, Yu Hsin

AU - Chiang-Ni, Chuan

AU - Chen, Chih Jung

AU - Lo, U. Ging

AU - Lin, Li Chiung

AU - Lin, Ho

AU - Hsieh, Jer Tsong

AU - Lai, Chih Ho

PY - 2016

Y1 - 2016

N2 - Cytolethal distending toxin (CDT), a genotoxin produced by Campylobacter jejuni, is composed of three subunits: CdtA, CdtB, and CdtC. CdtB is a DNase that causes DNA double-strand breaks (DSB) in the nucleus resulting in cell cycle arrest at the G2/M stage and apoptosis. CdtA and CdtC bind to cholesterol-rich microdomains on the cytoplasmic membrane, a process required for the delivery of CdtB to cells. Although a unique motif associated with cholesterol-binding activity has been identified in other pathogens, the mechanism underlying the interaction between the CdtA and CdtC subunits and membrane cholesterol remains unclear. Also, the processes of cell uptake and delivery of CdtB in host cells and the translocation of CdtB into the nucleus are only partially understood. In this review, we focus on the underlying relationship among CDT, membrane cholesterol, and the intracellular trafficking pathway as a unique mechanism for C. jejuni-induced pathogenesis. Moreover, we discuss the clinical aspects of a possible therapeutic application of CDT in cancer therapy. Understanding the molecular mechanism of CDT-host interactions may provide insights into novel strategies to control C. jejuni infection and the development of potential clinical applications of CDT.

AB - Cytolethal distending toxin (CDT), a genotoxin produced by Campylobacter jejuni, is composed of three subunits: CdtA, CdtB, and CdtC. CdtB is a DNase that causes DNA double-strand breaks (DSB) in the nucleus resulting in cell cycle arrest at the G2/M stage and apoptosis. CdtA and CdtC bind to cholesterol-rich microdomains on the cytoplasmic membrane, a process required for the delivery of CdtB to cells. Although a unique motif associated with cholesterol-binding activity has been identified in other pathogens, the mechanism underlying the interaction between the CdtA and CdtC subunits and membrane cholesterol remains unclear. Also, the processes of cell uptake and delivery of CdtB in host cells and the translocation of CdtB into the nucleus are only partially understood. In this review, we focus on the underlying relationship among CDT, membrane cholesterol, and the intracellular trafficking pathway as a unique mechanism for C. jejuni-induced pathogenesis. Moreover, we discuss the clinical aspects of a possible therapeutic application of CDT in cancer therapy. Understanding the molecular mechanism of CDT-host interactions may provide insights into novel strategies to control C. jejuni infection and the development of potential clinical applications of CDT.

KW - Campylobacter jejuni

KW - Cholesterol

KW - Cytolethal distending toxin

KW - Enzymatic activity

KW - Trafficking

UR - http://www.scopus.com/inward/record.url?scp=85006208775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006208775&partnerID=8YFLogxK

U2 - 10.3389/fcimb.2016.00009

DO - 10.3389/fcimb.2016.00009

M3 - Review article

VL - 6

JO - Frontiers in cellular and infection microbiology

JF - Frontiers in cellular and infection microbiology

SN - 2235-2988

IS - FEB

M1 - 9

ER -